Adaptive Biotechnologies

Price & Volume

Stats

See more
52W Range
$4.27-$15.57
Market Cap
$2.3B
Shares Short
9M

Financials

See more
Revenue (12 Mos)
$205.2M
Revenue Growth (YoY)
36.3%
Gross Profit (12 Mos)
$125.7M
Diluted EPS
-$0.81

About

CEO
Mr. Chad M. Robins M.B.A.
CFO
Mr. Kyle Piskel
Address
1165 Eastlake Avenue East, Seattle, WA, United States, 98109
Sector
Healthcare
Industry
Biotechnology
Full-Time Employees
619